New Epilepsy Drugs Seem Harmless to Pregnancies

A set of relatively new drugs used to treat epilepsy, bipolar disorder and migraine headaches does not appear to increase the risk of birth defects even when taken during the first trimester of pregnancy, a new Danish study says.

The study, the largest of its kind, sheds light on the safety of these drugs, during pregnancy . Older generations of antiepileptic drugs were known to increase the risk of major birth defects as much as threefold when taken while pregnant, but information was limited on the effect of the newer generation of drugs during pregnancy. These newer drugs, introduced after 1990, include lamotrigine, oxcarbazepine, topiramate, gabapentin, and levetiracetam.

Latest Videos From
Rachael Rettner
Contributor

Rachael is a Live Science contributor, and was a former channel editor and senior writer for Live Science between 2010 and 2022. She has a master's degree in journalism from New York University's Science, Health and Environmental Reporting Program. She also holds a B.S. in molecular biology and an M.S. in biology from the University of California, San Diego. Her work has appeared in Scienceline, The Washington Post and Scientific American.